ImmuneBiotech Medical AB

ImmuneBiotech AB - a microbiome company developing and marketing scientifically proven super-consortia of probiotic strains.
The first product, GutMagnific™ is patent pending and scientifically designed to address the underlying causes of IBS. The product was launched as probiotic food supplement in 2019. It is differentiated by effectively addressing multiple areas: microbial imbalance (dysbiosis), intestinal permeability and inflammation. GutMagnific™ has potential in many applications, such as diarrhea, antibiotic induced diarrhea, Clostridium difficile infection (CDI) and Chronic Fatigue Syndrome (ME/CFS).
ImmuneBiotech is building a pipeline within its concept of Companion Probiotics®, here selected probiotic combinations are designed for use together with existing drugs.